Novel Reversal Agent for Ticagrelor Gets FDA’s Breakthrough Therapy Designation
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to PB2452 (PhaseBio), an investigational reversal agent for ticagrelor.
Cardiology
Are Hospital Readmission Reduction Programs Truly Evidence Based?
When politicians attempt to make changes to health policy based on sentiments rather than on evidence-based conclusions, physicians often find themselves trying to meet unrealistic expectations.
Clinical Utility of Wearable Devices in Cardiac Rhythm Monitoring
Wearable devices can be used to diagnose cardiac rhythm abnormalities, but further investigation is necessary to optimize and integrate such technology into health care.
More Than a Third of Nonelderly Americans With ASCVD Have Financial Hardship
Researchers evaluated the national burden of financial hardship from medical bills among persons with atherosclerotic cardiovascular disease, as well as the fallout from such a problem, including financial distress, food insecurity, and cost-related medication nonadherence.
FDA Approves New Valsartan Product Following Major Recall
The Food and Drug Administration (FDA) has approved a new generic version of Diovan (Novartis) that does not contain N-nitrosodimethylamine (NDMA) or N-nitrosodiethylamine (NDEA), 2 potentially carcinogenic impurities identified in several recalled valsartan products.
Do CAD Outcomes Differ Between Those Enrolled in Medicare Advantage vs Fee-for-Service Medicare?
Researchers found that patients with coronary artery disease enrolled in Medicare Advantage had a slightly higher comorbidity burden and received higher quality care than their traditional fee-for-service Medicare counterparts.
Is It Time for Endocrinologists to Join the Vascular Care Team?
As the link between diabetes and PAD becomes more evident, clinicians can best serve patients with these comorbidities by working collaboratively to prevent serious complications.
Burden of Sudden Cardiac Death Higher in Black Men, Women
African Americans have a higher burden of sudden cardiac death than whites, especially among women.
Misconceptions About Heart Disease Are Widespread in United States
Many people in the United States don’t know that heart disease is the leading cause of death.
Patient, Consumer Groups Push for Injunction Against Short-Term Insurance Rule
The American Heart Association and others are urging the court to reconsider changes to short-term limited-duration insurance plans.
Next post in Policy
